Journal of Biological Chemistry · 2019 · 46 citations · 61 references
Veterinary MedicineBiotechnologyMolecular BiologyMolecular OncologyPrion DiseasesProtein EngineeringNeuropathology Of Prion DiseaseOncogenic Fusion GenesPrion Protein MisfoldingPrion Protein StructureEngineered ProteasesOncogenic Fusion ProteinsPrion Disease ModelsPrion PathogenesisPrion Protein Misfolding PatternsProtease-resistant Prion ProteinSarcoma-associated Fusion Genes
genes are also prone to chromosomal translocation events, which result in aberrant fusions between portions of the PrLDs of FUS and EWSR1 and the transcription factors CHOP and FLI. The resulting fusion proteins, FUS-CHOP and EWS-FLI, drive aberrant transcriptional programs that underpin liposarcoma and Ewing's sarcoma, respectively. The translocated PrLDs alter the expression profiles of these proteins and promote their phase separation and aggregation. Here, we report the development of yeast models of FUS-CHOP and EWS-FLI toxicity and aggregation. These models recapitulated several salient features of sarcoma patient cells harboring the FUS-CHOP and EWS-FLI translocations. To reverse FUS and EWSR1 aggregation, we have explored Hsp104, a hexameric AAA+ protein disaggregase from yeast. Previously, we engineered potentiated Hsp104 variants to suppress the proteotoxicity, aggregation, and mislocalization of FUS and other proteins that aggregate in ALS/FTD and Parkinson's disease. Potentiated Hsp104 variants that robustly suppressed FUS toxicity and aggregation also suppressed the toxicity and aggregation of FUS-CHOP and EWS-FLI. We suggest that these new yeast models are powerful platforms for screening for modulators of FUS-CHOP and EWS-FLI phase separation. Moreover, Hsp104 variants might be employed to combat the toxicity and phase separation of aberrant fusion proteins involved in sarcoma.
61
Masato Kato, Tina W. Han, Shanhai Xie et al. · Cell · 2012 · 2.1K citations · Full text
John R. Glover, Susan Lindquist · Cell · 1998 · 1.4K citations · Full text
α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models
Antony A. Cooper, Aaron D. Gitler, Anil G. Cashikar et al. · Science · 2006 · 1.4K citations · Full text
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Andrew C. Elden, Hyung Jun Kim, Michael P. Hart et al. · Nature · 2010 · 1.3K citations